{
  "Clinical Information": [],
  "Patent Information": [],
  "Sequence Information": {
    "ID": "AP04825",
    "Peptide Name": "6K-1426 (Synthetic AMPs, Temporin-WY2 analog, Lys-rich, Leu-rich, XXA, UCLL1c)",
    "Source": "Designed based an amphibian derived template",
    "Family": "Not found",
    "Gene": "Not found",
    "Sequence": "KKKKKKFLPKLLSALAKIL",
    "Sequence Length": 19,
    "UniProt Entry": "Ref",
    "Protein Existence": "Not found",
    "Biological Activity": [
      "Anti-Gram+",
      "Gram-",
      "Anti-MRSA",
      "Hemolytic",
      "Antibiofilm"
    ],
    "Target Organism": "Not found",
    "Hemolytic Activity": "Not found",
    "Cytotoxicity": "Not found",
    "Binding Target": "Not found",
    "Linear/Cyclic": "Not found",
    "N-terminal Modification": "Not found",
    "C-terminal Modification": "Not found",
    "Nonterminal Modifications and Unusual Amino Acids": "Not found",
    "Stereochemistry": "Not found",
    "Structure": "Helix",
    "Structure Description": "Not found",
    "Helical Wheel Diagram": "Not found",
    "PDB ID": "",
    "Predicted Structure": "Not found",
    "Formula": "Not found",
    "Absent Amino Acids": "Not found",
    "Common Amino Acids": "Not found",
    "Mass": "Not found",
    "PI": "Not found",
    "Basic Residues": "Not found",
    "Acidic Residues": "Not found",
    "Hydrophobic Residues": "Not found",
    "Net charge": 9,
    "Boman Index": 0.61,
    "Hydrophobicity": "Not found",
    "Aliphatic Index": "Not found",
    "Half Life": "Not found",
    "Extinction Coefficient Cystines": "Not found",
    "Absorbance 280nm": "Not found",
    "Polar Residues": "Not found",
    "Function": "Not found",
    "Hydrophobic residue%": "47%",
    "Crucial residues": ""
  },
  "Literature Information": {
    "Literature": "Sequence analysis: APD analysis reveals that this sequence is similar (80%) to6K-WY2Leu: 26%; K: 42%; A: 11%.Chemical modification:  C-terminal amidated.Activity: active against Gram+ bacteria S. aureus ATCC CRM 6538 or MRSA BAA 1707 or clinical MRSA B038 V1S1 A (MIC 8-16 uM), E. faecalis NCTC 12697 (MIC 16 uM), Gram- E. coli NCTC 8739 or clinical BAA 2340 (MIC 2 uM), P. aeruginosa ATCC 9027 or PA14 or PAO1 (MIC 2-16 uM), K. pneumoniae ATCC 43816 (MIC 2 uM).Antimicrobial robustness: NaCl-insensitive:E. coli (150 mM), KCl-insensitive:E. coli (4. 5 mM), NH4Cl-insensitive:E. coli (6 uM), CaCl2-sensitive:E. coli (2.5 mM), MgCl2-insensitive:E. coli (1 mM),  ZnCl2-insensitive:E. coli (8 mM), FeCl3-insensitive:E. coli (4 uM). Salt-insensitive:E. coli. NaCl-insensitized:P. aeruginosa PA14 (150 mM), KCl-insensitive:P. aeruginosa PA14  (4. 5 mM), NH4Cl-insensitive:P. aeruginosa PA14  (6 uM), CaCl2-insensitive:P. aeruginosai PA14  (2.5 mM), MgCl2-insensitive:P. aeruginosa PA14 (1 mM),  ZnCl2-insensitive:P. aeruginosa PA14 (8 mM), FeCl3-insensitive:P. aeruginosa PA14 (4 uM). Salt-insensitive:P. aeruginosa PA14. However, it is sensitive to PAO1: NaCl-sensitized:P. aeruginosa PAO1 (150 mM), KCl-sensitive:P. aeruginosa PAO1  (4. 5 mM), NH4Cl-sensitive:P. aeruginosa PAO1  (6 uM), CaCl2-sensitive:P. aeruginosai PAO1  (2.5 mM), MgCl2-sensitive:P. aeruginosa PAO1 (1 mM),  ZnCl2-sensitive:P. aeruginosa PAO1 (8 mM), FeCl3-sensitive:P. aeruginosa PAO1 (4 uM). Salt-sensitive:P. aeruginosa PAO1.  Human serum-insensitive:MRSA (%?).Biofilms: S. aureus: Inhibited formation (MBIC 4-8 uM). Disrupt preformed biofilms: E. coli (MBEC 32 uM).Structure:  random coils in NH4AC buffer and helical in 50% TFE.In vitro toxicity: horse RBC: HC50=32 uM.",
    "Author": "Liao F, Ye Z, Cheng J, Zhu J, Chen X, Zhou X, Wang T, Jiang Y, Ma C, Zhou M, Chen T, Shaw C, Wang L. 2024",
    "Reference": "Sci Rep. 2024 Aug 13;14(1):18769. doi: 10.1038/s41598-024-67777-1.PubMed",
    "Title": "Discovery and engineering of a novel peptide, Temporin-WY2, with enhanced in vitro and in vivo efficacy against multi-drug resistant bacteria"
  },
  "3D Structure": []
}